A response to a receptor antagonist can be brief even when the original drug and active metabolites remain in the body. Volney and Scatena described this distinction in a case of suspected chlordiazepoxide toxicity during alcohol withdrawal care.
What the response timeline showed
The patient became awake and able to follow commands after a flumazenil bolus, but the effect was short-lived. The team subsequently used a continuous infusion. When it was reduced during early taper attempts, lethargy recurred. The report also documented detection of chlordiazepoxide and nordiazepam later in the hospitalization.
What to separate in a forensic review
The bolus response is evidence about responsiveness under temporary antagonism. It cannot by itself establish that the original drug cleared or that every cause of reduced consciousness was resolved. Review the administered sedatives, specimen times, clinical observations and competing explanations in sequence. The case illustrates the distinction between temporarily changing a drug effect and eliminating the underlying exposure.
Leave a Reply